Improving the lives of patients is our TARGET—specifically those patients with certain cancers such as such as refractory melanoma, who have suffered without solutions for far too long. Each year, more and more patients are diagnosed and profoundly afflicted by these diseases. Yet there remains a large, unmet medical need to deliver life-altering and life-saving therapies for these patients. We believe the opportunities to help them and the medical community are squarely in front of us.
It’s what drives the Idera team every moment and rests at the core of all we do. We are laser-focused on translating our toll-like receptor technology into medicines that will target diseases unlike any other available treatment.